-

Thermo Fisher Scientific Adds New Ultra-Low Temperature Chest Freezer to Green Portfolio, Offering Eco-Friendly, Compliant, and Secure Cold Storage

Thermo Scientific TDE Series -80°C Chest Freezers, part of a larger green portfolio, offer rapid temperature recovery in as little as one minute

ASHEVILLE, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the addition of a new freezer to its ultra-low temperature (ULT) green portfolio, the Thermo Scientific TDE Series -80°C Chest Freezer. With increasing reliance on temperature-sensitive materials and therapeutics, laboratories require equally sensitive and highly consistent cold storage equipment. The freezer uses eco-friendly refrigerants and improved temperature regulation efficiency to offer approximately 25% reduction in energy usage for most size and voltages over the previous design.

Building off Thermo Fisher’s 80 years of experience developing cold storage solutions, the Thermo Scientific TDE Series -80°C Chest freezers, powered by H-drive hydrocarbon systems, deliver the reliability and enhanced performance required for vital research without compromising sustainability goals. With rapid temperature recovery after the door opens and tight peak variation, the TDE Series Chest Freezer is designed for both frequent entry and long-term storage applications. The use of natural refrigerants and insulation with extremely low Global Warming Potential (GWP) and Ozone Depleting Potential (ODP) levels far exceeds current regulatory requirements and ensures laboratory compliance with U.S. EPA SNAP & EU F-gas regulations.

“The new TDE Series Chest Freezer enables us to meet both performance and sustainability goals for our customers. Its hydrocarbon refrigerants are best-in-class for reducing global warming impact, and rapid temperature recovery improves energy efficiency within the lab,” said Chris Champlin, vice president and general manager of laboratory equipment, Thermo Fisher Scientific. “From our first ULT freezer in 1940 to this newest freezer, we continue to deliver new cold storage solutions that meet the evolving needs of our customers.”

The new TDE Series Chest Freezers are part of a full line of ultra-low temperature freezers that provide a wide range of capacities and configurations, enabling users to maximize their cold storage workflows.

For more information about the Thermo Scientific TDE Series Chest Freezer, please visit www.thermofisher.com/chestult.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Mauricio Minotta
Director, Public Relations
Thermo Fisher Scientific
+1 760-929-2456
Mauricio.minotta@thermofisher.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Mauricio Minotta
Director, Public Relations
Thermo Fisher Scientific
+1 760-929-2456
Mauricio.minotta@thermofisher.com

More News From Thermo Fisher

Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco. The new center provides pharmaceutical and biotechnology innovators with immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights and the development of life-saving therapies. Accelerating Drug Discovery with Cryo-EM The...

Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar**, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species — including Candida auris, a growing global antimicrobial resistance (AMR) threat1. Invasive fungal infections are an increasing challenge for healthcare systems w...

Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner

WEST HILLS, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType™ Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection. For transplant recipients, finding the right tacrolimus dose as early as possible can be life-changing. If the dose is too low, the body may...
Back to Newsroom